Together Pharma Ltd (TGTR.TA)
ILA 422.0
(-0.24%)
ILA 422.0
(-0.24%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 141.09 Million ILS | 11.3% |
| 2022 | 126.77 Million ILS | -4.64% |
| 2021 | 132.93 Million ILS | 20.29% |
| 2020 | 110.51 Million ILS | 38.25% |
| 2019 | 79.93 Million ILS | 59.28% |
| 2018 | 50.18 Million ILS | 2740.13% |
| 2017 | 1.76 Million ILS | -75.33% |
| 2016 | 7.16 Million ILS | -10.73% |
| 2015 | 8.02 Million ILS | -30.65% |
| 2014 | 11.56 Million ILS | 428.69% |
| 2013 | 2.18 Million ILS | 486.03% |
| 2012 | 373.37 Thousand ILS | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 106.81 Million ILS | -24.29% |
| 2024 Q2 | 106.81 Million ILS | 0.0% |
| 2023 Q4 | 141.09 Million ILS | 0.0% |
| 2023 FY | 141.09 Million ILS | 11.3% |
| 2023 Q1 | 128.19 Million ILS | 1.13% |
| 2023 Q2 | 128.19 Million ILS | 0.0% |
| 2023 Q3 | 141.09 Million ILA | 10.06% |
| 2022 Q3 | 126.77 Million ILS | 10.95% |
| 2022 Q4 | 126.77 Million ILS | 0.0% |
| 2022 Q1 | 114.26 Million ILS | -14.05% |
| 2022 FY | 126.77 Million ILS | -4.64% |
| 2022 Q2 | 114.26 Million ILS | 0.0% |
| 2021 Q4 | 132.93 Million ILS | 10.29% |
| 2021 Q3 | 120.53 Million ILS | 3.38% |
| 2021 Q2 | 116.59 Million ILS | 3.89% |
| 2021 FY | 132.93 Million ILS | 20.29% |
| 2021 Q1 | 112.23 Million ILS | 1.56% |
| 2020 Q4 | 110.51 Million ILS | 0.0% |
| 2020 Q1 | - ILS | -100.0% |
| 2020 Q2 | 98.26 Million ILS | 0.0% |
| 2020 FY | 110.51 Million ILS | 38.25% |
| 2019 FY | 79.93 Million ILS | 59.28% |
| 2019 Q4 | 79.93 Million ILS | 0.0% |
| 2019 Q3 | 79.93 Million ILS | 42.67% |
| 2019 Q2 | 56.03 Million ILS | 0.0% |
| 2019 Q1 | 56.03 Million ILS | 11.64% |
| 2018 Q3 | 50.18 Million ILS | 35.97% |
| 2018 FY | 50.18 Million ILS | 2740.13% |
| 2018 Q4 | 50.18 Million ILS | 0.0% |
| 2018 Q1 | 36.91 Million ILS | 0.0% |
| 2018 Q2 | 36.91 Million ILS | 0.0% |
| 2017 Q1 | 7.01 Million ILS | -1.99% |
| 2017 Q4 | - ILS | 0.0% |
| 2017 Q3 | - ILS | -100.0% |
| 2017 Q2 | 6.74 Million ILS | -3.9% |
| 2017 FY | 1.76 Million ILS | -75.33% |
| 2016 FY | 7.16 Million ILS | -10.73% |
| 2016 Q4 | 7.16 Million ILS | 6.2% |
| 2016 Q3 | 6.74 Million ILS | -12.2% |
| 2016 Q2 | 7.68 Million ILS | -6.7% |
| 2016 Q1 | 8.23 Million ILS | 2.62% |
| 2015 FY | 8.02 Million ILS | -30.65% |
| 2015 Q4 | 8.02 Million ILS | 1.74% |
| 2015 Q3 | 7.88 Million ILS | 10.85% |
| 2015 Q1 | 11.4 Million ILS | -1.44% |
| 2015 Q2 | 7.11 Million ILS | -37.61% |
| 2014 Q1 | 2.58 Million ILS | 18.19% |
| 2014 FY | 11.56 Million ILS | 428.69% |
| 2014 Q4 | 11.56 Million ILS | -3.51% |
| 2014 Q2 | 11.23 Million ILS | 334.44% |
| 2014 Q3 | 11.98 Million ILS | 6.71% |
| 2013 Q2 | 890.8 Thousand ILS | 46.29% |
| 2013 Q4 | 2.18 Million ILS | 175.76% |
| 2013 FY | 2.18 Million ILS | 486.03% |
| 2013 Q1 | 608.93 Thousand ILS | 63.09% |
| 2013 Q3 | 793.46 Thousand ILS | -10.93% |
| 2012 FY | 373.37 Thousand ILS | 0.0% |
| 2012 Q3 | 576.19 Thousand ILS | 0.0% |
| 2012 Q4 | 373.37 Thousand ILS | -35.2% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Cannabotech LTD | 9.68 Million ILA | -1356.55% |